News & Videos - ORASURE TECHNOLOGIES INC. - English

Thinking about buying stock in OraSure Technologies, Quipt Home Medical, Talkspace, Frontline, or Oncolytics Biotech? PR Newswire NEW YORK, June 1, 2023 NEW YORK , June 1, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OSUR, QIPT, TALK, FRO, and ONCY. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. OSUR:...

Thinking about buying stock in OraSure Technologies, Argo Blockchain, Pagaya Technologies, BioSig Technologies, or Roblox? PR Newswire NEW YORK, Feb. 15, 2023 NEW YORK , Feb. 15, 2023 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OSUR, ARBK, PGY, BSGM, and RBLX. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. OSUR:...

Thinking about buying stock in OpGen, Adverum Biotechnologies, OraSure Technologies, Sonnet BioTherapeutics, or Sio Gene Therapies? PR Newswire NEW YORK, Oct. 4, 2021 NEW YORK , Oct. 4, 2021 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OPGN, ADVM, OSUR, SONN, and SIOX. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. OPGN:...

...

Thinking about buying stock in OraSure Technologies, AMC Entertainment, Can Fite Biopharma, American Airlines, or Canopy Growth Corp? PR Newswire NEW YORK, Oct. 19, 2020 NEW YORK , Oct. 19, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for OSUR, AMC, CANF, AAL, and CGC. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. OSUR:...

Thinking about trading stocks or options in Burlington Stores, Floor & Decor Holdings, Sea Ltd, OraSure Technologies, or American Airlines Group? PR Newswire NEW YORK, May 22, 2020 NEW YORK , May 22, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for BURL, FND, SE, OSUR, and AAL. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different options trading strategies. The...

Thinking about buying stock in AMC Entertainment, Carnival Corp, OraSure Technologies, Inovio Pharmaceuticals, or Aytu Bioscience? PR Newswire NEW YORK, May 11, 2020 NEW YORK , May 11, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for AMC, CCL, OSUR, INO, and AYTU. To see how InvestorsObserver's proprietary scoring system rates these stocks, view the InvestorsObserver's PriceWatch Alert by selecting the corresponding link. AMC:...

NEW YORK, Nov. 28, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of OraSure Technologies, Inc. (NASDAQ:OSUR), Sierra Wireless, Inc. (NASDAQ:SWIR), Seres Therapeutics, Inc. (NASDAQ:MCRB), Lydall, Inc. (NYSE:LDL), ChromaDex Corporation (NASDAQ:CDXC), and Capricor Therapeutics, Inc. (NASDAQ:CAPR), including updated fundamental summaries,...

NEW YORK, NY / ACCESSWIRE / February 7, 2018 / OraSure Technologies, Inc. (NASDAQ: OSUR ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 7, 2018 at 5:00 PM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/22419 To receive updates for this company you can register by emailing [email protected] or by clicking get investment info from the company's profile. About Investor...

NEW YORK, NY / ACCESSWIRE / November 1, 2017 / OraSure Technologies, Inc. (NASDAQ: OSUR ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 1, 2017 at 5:00 PM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/22419 . To receive updates for this company you can register by emailing [email protected] or by clicking get investment info from the company's profile. About Investor...

NEW YORK, NY / ACCESSWIRE / May 3, 2017 / OraSure Technologies, Inc. (NASDAQ: OSUR ) will be discussing their earnings results in their Q1 Earnings Call to be held May 3, 2017 at 5:00 PM Eastern Time. To listen to the event live – visit https://www.investornetwork.com/company/22419 . Replay Information The replay will be available online at https://www.investornetwork.com/company/22419 . About Investor Network Investor Network (IN) is a new financial content community, serving millions of...

Grifols Strengthens Position as Global Provider of Diagnostic Testing Solutions with Five-Year Extension of OraSure Technologies Agreement and a New Manufacturing Facility - Longstanding relationship between companies fortified by multi-year contract extension - Grifols is currently building an $80 million manufacturing facility that will optimize production and expand capacity PR Newswire EMERYVILLE, Calif., April 24, 2017 EMERYVILLE, Calif. , April 24, 2017 /PRNewswire/ -- Grifols (MCE: GRF,...

VIDEO FINANCIAL REPORTING Why invest in is the first financial video platform where you can easily search through thousands of videos describing global ......

BETHLEHEM, Pa., Jan. 11, 2017 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR) has scheduled its regular earnings conference call covering 2016 fourth quarter financial results, 2017 first quarter financial guidance and certain business developments for 5:00 pm ET (2:00 pm PT) on Wednesday, February 8, 2017. February 8, 2017 Schedule 4:00 p.m. ET 2016 fourth quarter financial results press release will be distributed. 4:50 p.m. ET To participate in the conference call, dial...

BETHLEHEM, Pa., Nov. 29, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, announced today that it will begin fulfilling a contract to supply a foreign government with $18 million of product, primarily to support a nationwide hepatitis C (HCV) testing and treatment program with the goal of eliminating HCV infection across the country by 2020. The contract calls for the purchase of $16 million of OraQuick...

- Oragene ® ●Dx saliva collection kits to provide reliable DNA samples for Helix - BETHLEHEM, Pa., Nov. 29, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, announced today that Helix, the personal genomics company, has selected the Oragene ® Ÿ ● Dx device to provide reliable self-collection of DNA samples to be used in a genetic information discovery service offered by Helix for consumers....

BETHLEHEM, Pa., Nov. 21, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a market leader in point-of-care diagnostic tests and specimen collection devices, today announced that it will host an Analyst Day meeting on Tuesday, November 29, 2016 in New York City, New York, at the NASDAQ MarketSite at Times Square. Presentations by OraSure’s senior executive team are scheduled to begin at 10:00 a.m. (Eastern Time) and conclude by 1:00 p.m. (Eastern Time) and will cover various...

BETHLEHEM, Pa., Nov. 15, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced the appointment of Stephen S. Tang, Ph.D., as Chairman of the Company’s Board of Directors (the “Board”), effective November 14, 2016. Dr. Tang has been a Board member since April 2011, has served as Chairman of the Compensation Committee since May 2014 and is also a member of the Nominating and Corporate...

BETHLEHEM, Pa., Nov. 09, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point of care diagnostic tests and specimen collection devices, today announced that Douglas A. Michels, President and CEO, will speak to the investment community at the 10 th Annual Canaccord Genuity Medical Technology & Diagnostics Forum in New York. The conference will be simultaneously webcast over the Internet. Mr. Michels is scheduled to speak on November 17, 2016, at approximately 9:00...

BETHLEHEM, Pa., Nov. 02, 2016 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ:OSUR), a leader in point-of-care diagnostic tests and specimen collection devices, today announced its consolidated financial results for the three and nine months ended September 30, 2016. Financial Highlights Consolidated net revenues for the third quarter of 2016 were $32.3 million, an 8% increase from the third quarter of 2015. Consolidated net revenues for the nine months ended September 30, 2016 were $92.7...